785O PIVOT IO 001: First disclosure of efficacy and safety of bempegaldesleukin (BEMPEG) plus nivolumab (NIVO) vs NIVO monotherapy in advanced melanoma (MEL)

Adi Diab, Helen Gogas, Shahneen Sandhu, Georgina V. Long, Paolo A. Ascierto, James Larkin, Mario Sznol, Fábio Franke, T-E. Ciuleanu, E. Muñoz Couselo, A. Perfetti, Célèste Lebbé, Friedegund Meier, Brendan D. Curti, C. Rojas, Hwai‐I Yang, Ming Zhou, Shruthi Ravimohan, Mary Tagliaferri, N. Khushanlani